The Open Payments Database is a federal transparency program that requires manufacturers of drugs, medical devices, and biological products to report payments and other transfers of value made to physicians and teaching hospitals.

The information collected is made publicly available by the Centers for Medicare & Medicaid Services (CMS).

Patients and the public can review this information by visiting:

👉 https://www.cms.gov/openpayments

The purpose of the Open Payments program is to promote transparency and allow patients to better understand relationships between healthcare providers and industry.

If you have questions about the Open Payments program, you may visit the website above or contact CMS directly.